Roivant Sciences ROIV

NASDAQ ROIV

$41.81 +0.33 (+0.80%)

As of: Sep 9, 2026 · 3:59 PM EDT

Roivant Sciences (ROIV) FCF Margin Growth (5y) (2025 - 2026)

Analysis

Roivant Sciences (ROIV) FCF Margin Growth (5y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Amgen	211.73 Bn	197.74 Bn	7.24 Bn
2	Gilead Sciences	180.92 Bn	177.74 Bn	6.22 Bn
3	Vertex Pharmaceuticals	132.16 Bn	124.30 Bn	2.84 Bn
4	Regeneron Pharmaceuticals	82.89 Bn	74.90 Bn	3.93 Bn
5	Argenx Se	61.41 Bn	56.23 Bn	1.37 Bn
6	Moderna	53.99 Bn	48.85 Bn	52.00 Mn
7	Alnylam Pharmaceuticals	34.48 Bn	31.18 Bn	992.69 Mn
8	Biogen	31.15 Bn	29.86 Bn	1.96 Bn
9	Roivant Sciences	30.05 Bn	30.05 Bn	1.16 Mn
10	Insmed	27.99 Bn	26.83 Bn	358.27 Mn

Historic Data

Historic Data

Download Data

Date	Value
Jun 30, 2026	-1.68 Mn
Dec 31, 2025	-719,290.00
Jun 30, 2025	-253,136.00

Roivant Sciences

NASDAQ: ROIV

$41.81 ▲ +0.33 (+0.80%)

Sep 9, 2026 · 3:59 PM EDT